The Globe and Mail1h
Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024
a next generation multi-specific CD3 Switch-DARPin with enhanced function to tackle the current limitations of T cell engagers in ovarian cancer Both posters will be made available on Molecular ...
The Globe and Mail21h
ANGLE presents two posters at EACR
ANGLE presented two posters at the EACR Liquid Biopsies Conference: 1. Combined epitope-independent microfluidic isolation and advanced staining of circulating tumour cells isolated from metastatic ...
Indiatimes11h
Sequent Scientific Share Price
Sequent Scientific Ltd., incorporated in the year 1985, is a Small Cap company (having a market cap of Rs 5,088.48 Crore) operating in Pharmaceuticals sector. Sequent Scientific Ltd. key ...